Latest Fluicell News & Updates

See the latest news and media coverage for Fluicell. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Fluicell

Tissue engineering platform for regenerative medicine

fluicell.com
Headquarters
Mölndal, Sweden
Founded year
2012
Company type
Public company
Number of employees
2–20

Last updated

Latest news about Fluicell

In short: Fluicell achieved its first positive quarterly cash flow in late 2025, driven by strong revenue growth and strategic licensing for its Nexocyte platform.

Company announcements

  • Fluicell

    Fluicell publishes interim report for Q1 2026

    Net sales increase to 6.1 MSEK, 26 times higher than the previous year. EBITDA becomes positive at 3.4 MSEK. Patent granted in the EU.

  • Fluicell

    The nomination committee proposes Karin Jennbacken as new board member

    Karin Jennbacken is Executive Director at AstraZeneca with expertise in cardiovascular research and regenerative medicine. The proposal complements the board election to the annual general meeting 2026.

  • Fluicell

    The Nomination Committee proposes new board in Fluicell

    Niklas Frisk is elected as chairman and Alex Scheepers, Kader Abdul, Peter Kjäll as new board members. Re-election of Owe Orwar, Daniel Chiu and Carl Fhager.

  • Fluicell

    Fluicell publishes annual report for 2025

    The annual report is available on the Company's website and as an attached file. For more information, contact the CEO or CFO.

Unlock all announcements with a

Media coverage

  • Dagens industri

    Fluicell turned to profit in the first quarter

    Fluicell reports an operating result of 3.3 million kronor (-2.6) in the first quarter of 2026. Sales increased to 6.1 million kronor (0.2) with revenues of 8.4...

  • Dagens industri

    Fluicell increases sales - reduces loss

    The medical technology company Fluicell reports an operating result of -0.1 million kronor (-1.8) for the fourth quarter of 2025.

  • MarketWatch

    Fluicell AB

    Fluicell AB Annual cash flow by MarketWatch. View FLUI net cash flow, operating cash flow, operating expenses and cash dividends.

  • Life Science Sweden

    Fluicell receives EU patent - "Important breakthrough"

    The method that has been patented involves creating biological structures on surfaces via a multi-step process, and is an important part of the company's Nexocyte platform, which...

Unlock all articles with a

Never miss news about Fluicell

Track Fluicell and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fluicell competitors & trending companies

Browse news for competitors to Fluicell and other trending companies.